Last reviewed · How we verify
6-month treatment
At a glance
| Generic name | 6-month treatment |
|---|---|
| Sponsor | CHEOL WHAN LEE, M.D., Ph.D |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Impact of Equine-Assisted Therapy on Mental Health and Addictive Behaviors in Patients Receiving Addiction Treatment (NA)
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- Shared Decision-Making Decision Aid for Newly Diagnosed Breast Cancer : A Multi-Center Randomized Controlled Trial (NA)
- Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors (NA)
- MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease (NA)
- Assisted Identification and Navigation of Early Mental Health Symptoms in Children (NA)
- Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients (PHASE2)
- USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 6-month treatment CI brief — competitive landscape report
- 6-month treatment updates RSS · CI watch RSS
- CHEOL WHAN LEE, M.D., Ph.D portfolio CI